Zosano Pharma Corp Diluted Shares Outstanding (Weighted Average)
Zosano Pharma Corp reported Diluted Shares Outstanding (Weighted Average) of 4.25 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2022-05-13
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for the quarter ending 2022-03-31 was 4.25M shares, a 42.50% increase year-over-year.
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for the quarter ending 2021-12-31 was 119.07M shares, a 16.37% increase year-over-year.
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for the quarter ending 2021-09-30 was 115.77M shares, a 48.64% increase year-over-year.
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for the quarter ending 2021-06-30 was 108.94M shares, a 98.34% increase year-over-year.
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for fiscal 2021 was 112.06M shares, a 65.03% increase from fiscal 2020.
- Zosano Pharma Corp weighted average number of shares outstanding, diluted for fiscal 2020 was 67.91M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 4.25M shares 10-Q · filed 2022-05-13 | 61.66M shares derived: average of 2 quarters · filed 2022-05-13 | 79.69M shares derived: average of 3 quarters · filed 2022-05-13 | 87.01M shares derived: average of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | 119.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 117.42M shares derived: average of 2 quarters · filed 2022-03-17 | 114.59M shares derived: average of 3 quarters · filed 2022-03-17 | 112.06M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 115.77M shares 10-Q · filed 2021-11-10 | 112.35M shares derived: average of 2 quarters · filed 2021-11-10 | 109.73M shares 10-Q · filed 2021-11-10 | 82.50M shares derived: average of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | 108.94M shares 10-Q · filed 2021-08-10 | 106.66M shares 10-Q · filed 2021-08-10 | 71.41M shares derived: average of 3 quarters · filed 2022-05-13 | 73.03M shares derived: average of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | 2.98M shares 10-Q · filed 2022-05-13 | 52.65M shares derived: average of 2 quarters · filed 2022-05-13 | 61.06M shares derived: average of 3 quarters · filed 2022-05-13 | 59.53M shares derived: average of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | 102.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 90.10M shares derived: average of 2 quarters · filed 2022-03-17 | 78.38M shares derived: average of 3 quarters · filed 2022-03-17 | 67.91M shares 10-K · filed 2022-03-17 |
| 2020-09-30 | 77.88M shares 10-Q · filed 2021-11-10 | 66.41M shares derived: average of 2 quarters · filed 2021-11-10 | 56.44M shares 10-Q · filed 2021-11-10 | |
| 2020-06-30 | 54.93M shares 10-Q · filed 2021-08-10 | 45.60M shares 10-Q · filed 2021-08-10 |